Home / BXP.L : LSE

AI Analysis Fundamentals Video Analysis Similar

AI Analysis

How does BXP.L make money? Does BXP.L have pricing power? What's the Earnings Whisper? Will BXP.L profit more as the business scales? What is BXP.L's management track record? Is BXP.L's current price justified?

Beximco Pharmaceuticals Limited

58.5p +$16.00 (+37.65%)

LSE · 16 Sep 2026 07:00 UTC

Previous Close

58.5p

Day Range

58.5p - 58.5p

Year Range

0.42p65p

Market Cap

260.98M

AVG Volume

76.12K

Trailing/Forward PE

6.33/5.86

PEG ratio

0.45

Dividend Yield

3.97%

Next Earnings Date

2026-12-02

Primary Exchange

London Stock Exchange

Revenue (BDT)

BXP.L Revenue (BDT) by year
Period	Revenue (BDT)
2023	44.39B
2022	39.27B
2021	34.67B
2020	29.49B
2019	25.61B
2018	22.82B
2017	17.72B
2016	15.51B
2015	13.36B
2014	12.13B

Net Income (BDT)

BXP.L Net Income (BDT) by year
Period	Net Income (BDT)
2023	5.83B
2022	4.61B
2021	5.12B
2020	5.13B
2019	3.51B
2018	3.03B
2017	2.54B
2016	2.23B
2015	1.97B
2014	1.81B

Operating Income (BDT)

BXP.L Operating Income (BDT) by year
Period	Operating Income (BDT)
2023	8.57B
2022	7.22B
2021	6.9B
2020	6.65B
2019	5.61B
2018	5.07B
2017	4.03B
2016	3.45B
2015	2.91B
2014	2.63B

EBITDA (BDT)

BXP.L EBITDA (BDT) by year
Period	EBITDA (BDT)
2023	10.07B
2022	9.04B
2021	8.6B
2020	7.81B
2019	6.44B
2018	5.9B
2017	4.73B
2016	4.18B
2015	3.5B
2014	2.95B

Cash Flows (BDT)

BXP.L Cash Flows (BDT) by year
Period	Cash Flows (BDT)
2023	6.34B
2022	2.7B
2021	2.3B
2020	-837.15M
2019	3.27B
2018	-1.59B
2017	-3.24B
2016	-491.42M
2015	122.78M
2014	-1.3B

EPS (BDT)

BXP.L EPS (BDT) by year
Period	EPS (BDT)
2023	13.06
2022	10.34
2021	11.48
2020	11.5
2019	7.66
2018	6.8
2017	5.69
2016	5.05
2015	4.41
2014	4.07

Expenses (BDT)

BXP.L Expenses (BDT) by year
Period	Expenses (BDT)
2023	13.34B
2022	13.17B
2021	14.32B
2020	15.94B
2019	10.77B
2018	7.82B
2017	7.62B
2016	5.48B
2015	4.19B
2014	5.12B

Cash & Debt (BDT)

BXP.L Cash & Debt (BDT) by year
Period	Cash & Debt (BDT)
2023	1.05B
2022	1.14B
2021	1.17B
2020	675.47M
2019	635.02M
2018	933.86M
2017	733.13M
2016	1.16B
2015	1.73B
2014	2.38B

Debt ratios

BXP.L Debt ratios by year
Period	Debt ratios
2023	0.11
2022	0.3
2021	0.39
2020	0.28
2019	0.46
2018	0.69
2017	0.68
2016	0.26

Margins

BXP.L Margins by year
Period	Margins
2023	44.17%
2022	44.09%
2021	45.61%
2020	47.21%
2019	46.46%
2018	46.55%
2017	46.77%
2016	46.33%
2015	45.77%
2014	45.43%

Return on Capital

BXP.L Return on Capital by year
Period	Return on Capital
2023	11.23%
2022	9.69%
2021	11.48%
2020	13.72%
2019	10.72%
2018	10.16%
2017	9.27%
2016	8.88%
2015	8.52%
2014	8.42%

Shares Outstanding

BXP.L Shares Outstanding by year
Period	Shares Outstanding
2023	446.11M
2022	446.11M
2021	446.11M
2020	446.11M
2019	446.11M
2018	446.11M
2017	446.11M
2016	446.11M
2015	446.11M
2014	446.11M

Dividends (BDT)

BXP.L Dividends (BDT) by year
Period	Dividends (BDT)
2026	2.32
2024	3.35
2023	3.17
2022	3.32
2021	3.97
2020	1.77
2019	1.13
2018	1.26
2017	1.24
2016	1.61

Book Value Per Share (BDT)

BXP.L Book Value Per Share (BDT) by year
Period	Book Value Per Share (BDT)
2023	116.34
2022	106.74
2021	100.06
2020	83.76
2019	73.52
2018	66.94
2017	61.31
2016	56.2
2015	51.69
2014	48.27

Total Assets (BDT)

BXP.L Total Assets (BDT) by year
Period	Total Assets (BDT)
2023	69.34B
2022	69.16B
2021	66.15B
2020	52.25B
2019	50.12B
2018	49.21B
2017	43.74B
2016	34.08B
2015	31.15B
2014	30.1B

No video analysis for this stock yet. Request one from our team.

AI Analysis

Beximco Pharmaceuticals Limited

Video analysis: BXP.L

Similar companies